Skip to main content
Cell Adhesion & Migration logoLink to Cell Adhesion & Migration
. 2013 Jan 1;8(3):215–225. doi: 10.4161/cam.27842

The interplay between the proteolytic, invasive, and adhesive domains of invadopodia and their roles in cancer invasion

Or-Yam Revach 1, Benjamin Geiger 1,*
PMCID: PMC4198345  PMID: 24714132

Abstract

Invadopodia are actin-based protrusions of the plasma membrane that penetrate into the extracellular matrix (ECM), and enzymatically degrade it. Invadopodia and podosomes, often referred to, collectively, as “invadosomes,” are actin-based membrane protrusions that facilitate matrix remodeling and cell invasion across tissues, processes that occur under specific physiological conditions such as bone remodeling, as well as under pathological states such as bone, immune disorders, and cancer metastasis. In this review, we specifically focus on the functional architecture of invadopodia in cancer cells; we discuss here three functional domains of invadopodia responsible for the metalloproteinase-based degradation of the ECM, the cytoskeleton-based mechanical penetration into the matrix, and the integrin adhesome-based adhesion to the ECM. We will describe the structural and molecular organization of each domain and the cross-talk between them during the invasion process.

Keywords: invadopodia, cancer metastasis, cell adhesion, invasion, metalloproteinases, cytoskeleton

Preface

Invadopodia are actin-based protrusions of the plasma membrane that penetrate into the extracellular matrix (ECM) and enzymatically degrade it.1-3 They belong to a family of structures, called invadosomes,4 which facilitate cell invasion through tissues, a process that occurs under specific physiological conditions such as wound repair, pathogen infection, embryogenesis, and cell differentiation, as well as under pathological conditions such as cancer metastasis.5

The first indication of invadosome family structures came in 1980, when David-Pfeuty and Singer observed, in chicken embryo fibroblasts, the relocalization of vinculin and α-actinin from focal adhesions into circular “rosettes,” following transformation with Rous sarcoma virus (RSV).6 Five years later, these v-src induced structures were defined by Tarone and Marchisio as “podosomes”7, due to their foot-like morphology. Later, more of their structural and signaling components, such as actin,8 fimbrin,9 and the oncogenic v-src itself,10,11 were identified, and RSV-induced podosomes were shown by Parsons et al. to be ECM contacts that also serve as sites of local matrix degradation.11 Their capacity to invade and degrade the ECM led Chen, in 1989, to name these structures “invadopodia.”12 Chen and colleagues continued to characterize these structures, and demonstrated their dependence on metalloproteinase degradation activity,12 tyrosine phosphorylation,12 and matrix adhesion.13-16 Similar adhesive and degradative structures were found in normal cells such as macrophages,17 osteoclasts,14,18 dendritic cells,19 vascular smooth muscle cells,20 and endothelial cells,21 as well as in a wide variety of metastatic cancer cell lines such as breast carcinoma,22 melanoma,16 bladder carcinoma,23 head and neck carcinoma,24 prostate cancer,25 and a variety of primary tumors.26

Despite the overall similarity between invadopodia, podosomes, and src-induced invadosomes, they do vary in their size, shape, density, and stability.1,4 Under a fluorescent microscope, invadopodia of cultured cancer cells usually appear as dot-like structures, with an F-actin core, containing several actin-binding proteins and signaling molecules.2,5 The cores can be scattered or clustered at the cell center, usually in close proximity to the nucleus.1 Podosomes, on the other hand, can be distributed in various fashions. They can be located throughout the cell in marcrophages, located at the cell periphery in smooth muscle cells, forming rosette-shaped clusters in endothelial cells, and in unique super-structures, such as sealing zones, in osteoclasts.4 Src-induced invadosomes in fibroblasts display rosette-shaped peripheral invadosomes.4

Invadopodia are long-lived, stable structures that last up to a few hours,27,28 as opposed to podosomes, whose lifespans is in the order of few minutes.5 The podosome actin core is surrounded by an adhesion ring containing plaque proteins such as vinculin, paxilin, and talin,4,29 whereas the adhesion component of invadopodia is still poorly characterized. Invadopodia and podosomes also differ in their degree of penetration into the ECM: invadopodia were shown to penetrate deep into the matrix30 and form filament-like processes, while podosomes display shallow appearance4 and, fail to form long membrane protrusions.31 Both podosomes and invadopodia degrade the ECM by local secretion of proteolytic enzymes; as indicated, podosomes tend to degrade the exposed surface of the matrix, while invadopodia, usually, penetrate deeper, into the ECM.1,4 Invadopodia, podosomes, and src-induced invadosome also display different activation pathways for core components such as the arp 2/3 complex, whose activation in invadopodia require NCK1, while in src-induced invadosomes the activation is mediated by Grb2. In podosomes of macrophages, the activation is not mediated by either one of the proteins.32 This emphasizes the fact that while these structures are molecularly similar, and perform similar functions there might act via different pathways.

In this review, we will focus on the functional architecture of invadopodia in cancer cells, addressing the mechanisms underlying the proteolytic and mechanical remodeling of the ECM by them. We will describe the structural and molecular organization of invadopodia and the roles of the proteolytic domain, the invasive domain and the adhesive domain (Fig. 1A and B; proteins presented in 1A are bolded in the text), and discuss the cross-talk between them during the invasion process.

graphic file with name cam-8-215-g1.jpg

Figure 1. Mapping of the signaling cascades associated with the proteolytic, invasive, and adhesive domains of invadopodia. The proposed signaling and protein interaction cascades associated with the formation of invadopodia, their adhesion to the matrix, and their penetration into it. Key components involved in these processes, their upstream regulators and downstream targets are shown. Proteolytic domain: ECM degradation by invadopodia is attributed to the activation and function of matrix metalloproteinases (MMPs). The membrane-bound form MT1-MMP is the master regulator of the degradation process, together with the secreted proteases MMP9 and MMP2. The synthesis and secretion of proteases is mediated by the ER and Golgi systems that deliver MMP-containing vesicles along microtubules. One of the central regulators of this process is src tyrosine kinase, which is activated upon receptor tyrosine kinase (RTK) activation. Src phosphorylates MT1-MMP and promotes its clathrin-mediated endocytosis and recycling, a process that promotes the transport of active MT1-MMP to the plasma membrane. Other downstream effectors of the RTK signaling cascades are the small GTPases, Rho A and CDC42, which can activate IQGAP interaction with sec8, a component of the exocytosis machinery that further promotes the delivery of MT1-MMP to the plasma membrane. Another mechanism for MT1-MMP recruitment to invadopodia involves phosphorylated cortactin, in a mechanism that is src- and Arg kinase-dependent. As a master regulator, MT1-MMP can also cleave and activate the secreted MMP9 and MMP2. Invasive domain: Assembly of an invasive actin network is induced by activation of RTKs (e.g., the EGF receptor), which leads to src and PKC kinase activation, as well as recruitment of adaptor molecules such as NCK1. NCK1 binds to WIP (WASP interacting protein) and block its inhibitory interaction with N-WASP, thus enabling N-WASP binding to Arp 2/3 and activating actin nucleation. The Arp 2/3 complex can nucleate actin polymerization on existing filaments, forming a branched actin network. The Arp 2/3 actin nucleation activity is promoted by the serving activity of cofillin, which forms free barbed ends on existing actin filaments. In response to PKC kinase activation, phosphoinositides (PI) are generated at the inner aspect of the plasma membrane of newly forming invadopodia. The adaptor protein TKS5 is recruited to the plasma membrane by binding to PIs, and is phosphorylated by src. The phosphorylated and membrane-associated TKS5 recruits cortactin that is also phosphorylated by src. In its unphosphorylated form, cortactin binds to cofilin, and inhibits it. Upon phosphorylation, cortactin detaches from cofilin, enabling it to sever actin filaments. Active cortactin facilitates both actin filament bundling and recruitment of MT1-MMP (see “proteolytic domain”). PKC can also activate the actin bundling protein fascin, which stabilizes the actin bundle. Adhesive domain: The adhesive domain of invadopodia is a ring-shaped structure associated with the periphery of the interface between the actin core bundle and the ventral plasma membrane (see “invasive domain”). This domain assembles within seconds to minutes following core formation. The assumption is that the adhesion ring is molecularly similar to other types of integrin-mediated adhesions (e.g., focal adhesions; see also Fig. 2, white arrow). It is suggested that activation of integrins, upon binding to ECM ligands in invadopodia sites, induces the local recruitment of adhesion plaque proteins such as vinculin, paxillin, and Hic-5. IQGAP also localizes to the adhesion domain, and possibly interacts with the plaque proteins and facilitates the exocytosis of MT1-MMP (see “proteolytic domain”). (B) Organization of the different functional domains of invadopodia. A schematic representation of the structural organization of invadopodia domains (cross-section) is shown. Each domain is denoted in different color. The proteolytic domain (in orange) includes the ER and Golgi systems, which produce protease-containing vesicles and transfer them to the invadopod. Anchoring and secretion of MMP-containing vesicles are apparent in close proximity to the membrane (see “proteolytic domain,” Fig. 1A), as are recycling and exocytosis of the membrane-bound MT1-MMP. The invasive domain (in black) is localized inside invadopodial protrusions into the ECM. This domain is composed of actin and actin-associated proteins (see invasive domain Fig. 1A). The protein interactions within this domain lead to actin polymerization in a branched and parallel fashion. The polymerizing actin bundles generate forces that are applied on the ECM and push the ventral cell membrane toward it. Around the core, at the protrusion’s edges the adhesive domain is localized, anchored to the ECM via integrins, and associated adhesome cytoplasmic plaque proteins. This adhesion can mechanically support the invasive process. Most of the cross-talk between the three domains occurs upon recruitment of the various components to the plasma membrane, at the site of forming invadopodia. This cross-talk orchestrates the force generation mechanism which is applied to the matrix, together with mechanical stabilization by adhesion and matrix degradation, ultimately driving the invasion and migration of the cell into the matrix.

The Proteolytic Domain

(Fig. 1A [middle panel] B). The matrix degradation capacity of invadopodia is attributed to a variety of proteases, belonging to the metalloproteinase (MMPs), ADAM, and serine protease families.1,5,33,34 Among these, the MMPs were shown to be the most functionally significant proteases associated with invadopodia activity in cancer cells. MMPs comprise a large family of zinc-dependent enzymes, both membrane-bound and soluble,1which are capable of cleaving multiple ECM proteins35. The membrane-bound form, MT1-MMP (or MMP14), was shown to be not just an invasion-promoting component, but also a master regulator of invadopodia development,33,36 whose recruitment promotes invadopodia maturation.2 MT1-MMP displays intrinsic collagenolytic activity, and can also cleave and activate some of the soluble MMPs.34,37 Soluble MMP9 and MMP2 are secreted around invadopodia, and promote local ECM degradation.16,35-41 Blocking MMP activity by inhibitors, antibodies, or siRNA impairs invadopodia function and matrix degradation.1,5 Furthermore, MMP inhibition also inhibits invadopodia formation, suggesting that MMPs regulate and fine-tune invadopodia function, at early stages of their formation.2,5

The mechanisms where by proteases are recruited to sites of invadopodia remain unclear, and likely involve several recruitment pathways (Fig. 1A and B; proteolytic domain). These include vesicle trafficking along microtubules, which was demonstrated for MMP2 and MMP9 in melanoma cells.42 MT1-MMP is also regulated by clathrin-mediated and caveolar endocytosis;40 its recycling is suggested as a means of generating a membrane-active enzyme.43 Polarized exocytosis and transport of vesicles of MT1-MMP to sites of invadopodia is regulated by Rab8 GTPase in breast cell carcinoma.44 In macrophages Rab5a, Rab8a, and Rab14 were shown to be important for MT1-MMP polarized transport.45 MT1-MMP can be phosphorylated in a src-depended manner;46 and such phosphorylation was shown to promote clathrin-mediated endocytosis.40 Exocytosis was also shown to be involved in MT1-MMP regulation via IQGAP, a key regulator of cell polarity, which connects the actin cytoskeleton to microtubules.47 Upon activation of RhoA and CDC42, IQGAP is localized to invadopodia together with sec8, a component of the exocytotic machinery; together, they regulate the docking of MT1-MMP vesicles to the plasma membrane.48 Furthermore, the actin polymerization regulator cortactin was shown to participate in the recruitment of MMPs to invadopodia, and regulate their secretion.36,39,49 The adhesion machinery is also thought to play a role in invadopodia maturation and matrix degradation: β1 integrin co-clusters with MT1-MMP at sites of interaction with collagen fibers along the cell’s leading edge.50,51 In addition, inhibition of integrin-mediated adhesion reduces recruitment of IQGAP to invadopodia, as well as matrix degradation.52 A possible mechanism for protease recruitment by β1 integrin involves Arg kinase, which can phosphorylate cortactin on tyrosin 421 and promote matrix degradation.53 Finally, dynamin 2 was shown to regulate the local matrix degradation in invadopodia, through proper localization and its GTPase activity.54,55

Cancer cells are commonly associated with elevated levels of MMPs, whose expression is correlated with cancer aggressiveness and poor prognosis.40,56 Thus, studies of their activation and of mechanisms that could inhibit their activity are of great medical interest. Treating cancer with MMP inhibitors was considered to be a very promising approach and was studied in a variety of clinical trials as therapy for various types of cancers.57-59 Unfortunately, those trials were largely unsuccessful, most likely due to the development of drug resistance by the tumor cells,60 secretion of MMP from stroma cells around the tumor,61 lack of sufficient specificity of the inhibitors, and changes in the cancer cell migration and invasion mechanism, capable of switching from proteolysis-dependent migration to amoeboid migration (a so-called “mesenchymal–amoeboid transition”).50,62

The failure of MMP inhibition to block cancer invasion indicates that the remodeling of the ECM per se is not sufficient for preventing cancer invasion and metastasis, and suggests that cell invasion into the matrix requires an active migratory process, whereby cancer cells “force their way” into the matrix. This mechanical penetration is primarily attributed to the invasive domain of invadopodia.

The Invasive Domain

General overview

(Fig. 1A [right panel] and B). Local matrix invasion, driven by invadopodia, is a highly coordinated process, whereby enzymatic ECM degradation and mechanical cytoskeletal “pushing” occur at approximately the same time and in the same area, ultimately leading to effective penetration of the cell protrusion into the matrix. Considerable efforts were invested in characterizing the mechanical component of this process, which is believed to be driven primarily by actin polymerization, in a manner similar to the protrusive phase observed in the lamellipodia of migratory cells.1-3,5 In this section, we will introduce the overall structure and assembly of the cytoskeletal machinery of invadopodia, and then discuss the specific contributions of each component to the overall process.

The temporal sequence of events that eventually leads to invadopodia formation is not fully understood; yet it has been proposed that this process is initiated by ligand-induced activation of receptor tyrosine kinases, such as the EGF receptor 28,63 (Fig. 1A and B). This signaling event triggers the activation of c-src,7,64-66PKC isoforms,67-70 and eventually, the adaptor protein TKS5,71 which plays a key role in early stages of the assembly of the actin machinery, TKS5 can then bind to Ptdlns(3,4)P2 at the plasma membrane, promoting the recruitment of actin regulators such as the SH2/SH3-containing, signaling adaptor protein NCK1 to the membrane.2

The exact temporal sequence of these events is still not elucidated. A new approach of high-resolution spatiotemporal live cell imaging, published recently, shows that cortactin, N-WASP, cofilin, and actin arrive simultaneously to form the invadopodia precursor, while TKS5 is recruited later and is required for the structure stabilization.72

Actin polymerization in the core of invadopodia is regulated by small Rho-family GTPases, mostly, CDC42,1,28 which can directly activate the N-WASP-WIP complex, which, in turn, drives actin polymerization by the Arp2/3 complex.73-76 Arp 2/3 actin nucleation is promoted by the severing activity of cofillin.77-79 Additional reports indicate that actin polymerization in invadopodia of certain cancer cells (e.g., MDA-231 breast cancer cell line) can also be induced by specific Diaphanous-related formins, whose cell type specificity, and mode of action and regulation, are still unclear.80 The actin bundle, thus formed, is further stabilized and mechanically reinforced by cortactin5 and fascin,73,81,82 producing a stable “invasive protrusion” that pushes against the ventral cell membrane, promoting its penetration into the ECM.5,27,28,36,39,68,83

To get a closer look at the constituents of the invasive domain (Fig. 1A and B; invasive domain) we summarized below the modes of action of the major proteins that are believed to participate in invadopodia nanomechanics:

(1) The adaptor protein N-WASP and its regulators were previously shown to be an essential component of invadopodia.28,84 N-WASP elimination reduced the ability of mammary adenocarcinoma cells to form invadopodia, and metastasize.26 N-WASP, together with WASP in hematopoietic cells and WAVE 1–3, are major regulators of actin cytoskeleton dynamics.26 Mutations in WASP are known to cause an X-linked inherited disease, Wiskott–Aldrich syndrome, characterized by immunodeficiency. WASP is negatively regulated by WASP-interacting protein (WIP), which is removed upon stimulation by upstream regulators such as NCK1.85 In invadopodia, N-WASP is a direct effector of CDC42,5 and is regulated by upstream signals from NCK, src, and phosphoinositides.26 N-WASP is characterized by a C-terminal catalytic verprolin homology and a central acidic (VCA) domain, which mediate activation of the Arp2/3 complex. Activation of Arp 2/3 leads to actin polymerization, which generates the mechanical force that enables invadopodia to penetrate the ECM.86,87 N-WASP was recently suggested to bind to barbed ends and accelerate actin assembly and polymerization in an Arp 2/3-independent manner.88

(2) The Arp2/3 complex drives the nucleation of a new actin filament that branches off an existing filament.5 Arp2/3 is a 7-subunit complex composed of Arp2, Arp3, and five additional subunits (ARPC1–589). Arp2/3 is associated with invadopodia, and its knockdown by siRNA, or preventing N-WASP from binding to it, inhibits invadopodia formation.27,28 The Arp2/3 complex, together with N-WASP, is upregulated in tumors and invading cells.90,91 Stabilization of the actin polymerization capacity of the Arp 2/3 complex is attributed to the binding of Arp 2/3 to both N-WASP and cortactin, the latter also binds to actin, and stabilizes the filament.76,92,93

(3) Cortactin is a cytoskeletal, multi-domain protein that is important for the induction of actin polymerization.30,63,94 Cortactin is ubiquitously expressed, and can be phosphorylated by src kinase.95,96 Cortactin phosphorylation was shown to be an Arg kinase-dependent process, triggered by EGFR activation, and leading to invadopodia maturation.97 Tyrosin phosphorylation by src facilitates the response of cortactin to upstream signaling, including dynamic changes in the actin cytoskeleton.98 Phosphorylation of Y421, Y466, and Y482 in the proline-rich domain is necessary for metastatic dissemination of breast carcinoma cells,99 while Y421 and Y466, but not Y482, are required for the generation of free barbed ends of actin filaments of invadopodia.100 When phosphorylated, cortactin releases cofilin, and enables it to sever actin filaments, in order to form barbed ends that promote Arp 2/3 actin polymerization.77,92,101 Cortactin can also bridge between the Arp 2/3 complex and the actin bundle, due to its Arp 2/3 binding N-terminal acidic domain, and thus, serves as an actin stabilizer.102 Blocking cortactin activity by means of inhibitory antibodies, inhibition of src phosphorylation, or cortactin knockdown by siRNA,68 block both the formation of invadopodia and matrix degradation. Interestingly, besides its role in the regulation of the actin machinery, cortactin is believed to directly connect the cytoskeletal components of invadopodia to the proteolytic machinery.36,39,103

(4) Cofilin was shown to promote actin polymerization by its severing activity, which generates free barbed ends that induce the nucleation of actin polymerization by the Arp 2/3 complex.5,77-79 Cofilin was shown to be important for invadopodia stabilization, most likely due to its interaction with cortactin (see above) and in its absence invadopodia become small and short-lived.28 Cofilin severing activity is regulated and confined to invadopodia by RhoC and its upstream regulators p190RhoGEF and p190RhoGAP.104 RhoC regulation on cofilin is mediated by regulation on cofilin phosphorylation through Rho-associated protein kinase and LIM-domain kinase.79,104

(5) Fascin is an actin-bundling protein that cross-links actin filaments into a tightly packed bundle.105,106 In humans, there are three members of the fascin family (1–3), of which fascin 1 is the most widely expressed in tissues.107 The actin bundling capacity of fascin is attributed to the actin-binding sites at its N- and C-termini,108,109 and the bundling activity in invadopodia is specifically attributed to a PKC phosphrylation site at serine 39.81 Fascin is upregulated in cells localized at the invasive front of various invasive cancers.110,111 Fascin is important for invadopodia elongation and actin filament stability, and its depletion was shown to reduce the ability of invadopodia to degrade the ECM.81,83

(6) Other cytoskeletal systems, besides the actin network, namely, microtubules, and intermediate filaments, are believed to play either direct or indirect roles in invadopodia formation and function.

Little is known about the specific mechanisms underlying the roles of microtubules and intermediate filaments in invadosomes in general, and particularly, in invadopodia of cancer cells. Nevertheless, intact microtubules are required for the function of other invadosomes, such as podosomes of monocytes, macrophages, and osteoclasts1,112,113. In breast cancer cells, intact microtubules are not necessary for invadopodia formation,114,115 but their destruction affects invadopodia elongation and maturation.83 In melanoma cells, disruption of microtubules by inhibitory drugs causes invadopodia disassembly, inhibits their de novo formation, and consequently, reduces matrix degradation.116 Previous studies also show that transport of proteins toward the leading edge of migrating fibroblasts requires intact, functioning microtubules,117 a process that is thought to be important for the polarized transport of MMPs to invadopodia.116

Intermediate filaments were shown to interact with actin filaments via fimbrin during the formation of podosomes in macrophages.118 Vimentin intermediate filaments are localized to newly formed podosomes of vascular smooth muscle cells, but are not directly necessary for their formation. In invadopodia, vimentin, but not cytokeratin, was shown to play a role in the invadopodia elongation.83

To summarize, various proteins of the actin machinery work together in order to form a dense web of a dendritic actin network and long parallel bundles, which, together, apply mechanical force that pushes the plasma membrane toward and into the ECM. Other cytoskeletal elements; namely, microtubules and intermediate filaments, are believed to affect the elongation stage of invadopodia; but their specific roles are yet to be explored.

The mechanical force generated by actin polymerization plays a key role in invadopodia protrusive action, but several mechanistic questions still remain open: Is inavdopodia protrusive activity sufficient for driving the entire process of cell invasion? What prevents a protrusion from retracting? What mechanisms coordinate, spatially, tumor cell “proteolytic invasion” and migration? What keeps the actin network from extending deep into the cytoplasm rather than pushing the plasma membrane?

The Adhesive Domain

(Fig. 1A [left panel] and B). Tissue cells grow and function in tight association with diverse components of the ECM. These adhesive interactions play a central role in tissue morphogenesis and remodeling, as well as in physiological and pathological cell migration. Cells connect their cytoskeleton to ECM components via a variety of specialized transmembranal receptors, the most common of which are the heterodimeric integrins.119 Integrins interact with the ECM components via their extracellular domains, and are connected to the actin cytoskeleton via their cytoplasmic tails, and a multi-protein complex of adaptor, scaffold, and signaling proteins, known collectively as the integrin adhesome.120,121 In addition to their mechanical role, integrin adhesions to the ECM act as “multi-sensory” sites, enabling cells to “scan” the ECM, and respond to its chemical-molecular properties, as well its physical characteristics, including rigidity, stretching,122-125 and topography of the ECM.126-130

It is commonly accepted that the spatiotemporally regulated coupling between protrusive processes and the establishment of nearby adhesions is essential for cell locomotion and invasion.63,131,132 During the migration process, for example, the forward extension of lamellipodia or filopodia, driven by local actin polymerization, is guaranteed by the presence of focal adhesions or focal complexes at the posterior aspects of these protrusions.131,133

Do matrix adhesions play an essential role in ECM invasion by invadopodia, or is this process primarily driven by MMPs that locally degrade the matrix? Over the years, researchers have addressed this question, yet information about the adhesive domain of invadopodia, its molecular composition, and its structure, remains scarce. Previous studies suggest that invadopodia of cancer cells lack a distinct adhesive capacity, unlike podosomes, which contain a conspicuous adhesive ring.3,4 It is noteworthy that podosomes, have typical lifetimes on the order of a few minutes, while invadopodia can be stable for hours.1 More recently, these claims were challenged by the detection of vinculin, paxillin, and Hic-5 in rings located at the periphery of newly formed invadopodia in various cultured cancer cell lines52,134 (and our unpublished data Fig. 2). It is likely that this apparent discrepancy is attributable to differences between the cancer cell lines, or to variations in the persistence of the adhesion rings during the lifespan of the invadopodia. In fact, it was reported that the adhesive domain of invadopodia is formed soon after the formation of the core F-actin bundle, showing an oscillatory behavior, and occasionally, disappears at later stages, after stabilization of the structure52,72 (and our unpublished data). The mechanisms underlying the interplay between the core and the adhesion ring, and their significance for ECM remodeling, are still poorly understood.

graphic file with name cam-8-215-g2.jpg

Figure 2. The actin core and adhesion ring of invadopodia: A375 cells were cultured on gelatin-coated glass bottomed dishes for 2h. Cells were fixed and stained for TKS5, an invadopodia core marker, and vinculin, a marker for integrin adhesions. The adhesion ring (shown enlarged in the upper-right corner) is associated with the invadopodia core at early stages (within minutes) of invadopodia formation, and often disappears at later stages (hours). Stable focal adhesions (FAs), located mainly at the cell’s periphery, are also formed in these cells.

Nevertheless, it was shown that integrin-mediated adhesion regulates invadopodia formation by activation of Rho GTPase family members and various kinases, together with recruitment of adhesion molecules53,135,136 (Fig. 1A and B; adhesive domain). Several integrins were shown to be associated with invadopodia, including α6β1 in melanoma135,136 and α3β1 in breast cancer cells,53,137 suggesting that the association of integrins with invadopodia is tissue-specific. Within the adhesion sites, integrins are believed to bind and activate metalloproteases, besides their “classical” signaling and scaffolding functions. Blocking of integrin-mediated adhesion by soluble RGD peptides or inhibitory antibodies results in reduced matrix degradation, and less localization of MT1–MMP to invadopodia sites.52

Integrins are not the only players in the adhesive domain of invadopodia. In order to form stable adhesions with the ECM and link them to the cytoskeleton, various components of the integrin adhesome, including scaffolding and signaling molecules, are recruited to the adhesion site.138-141 For example, the adaptor protein paxillin142 is tyrosine-phosphorylated, and can form a complex with PKCμ and cortactin in invadopodia.68 Hic-5, a member of the paxillin family, localizes to invadopodia rings, and upon TGFβ stimulation, promotes ECM degradation in a src phosphorylation-dependent manner.134 The role of Focal Adhesion Kinase in invadopodia regulation is rather controversial; it was shown to function as a negative regulator of invadopodia through the spatial control of src in MTLn3 mammary adenocarcinoma cells,143 While other reports indicate that it is localized to invadopodia, and its increased expression promotes the formation of src-induced invadopodia.144 VASP, another adhesome component, accumulates at the degradation sites of invadopodia in MDA-231 breast cancer cells83 and its phosphorylation on Ser239 was reported to suppress invadopodia formation, and inhibit the formation of cancer metastasis.145

Like other adhesion structures, invadopodia are highly regulated by the chemical and physical properties of the ECM. Matrix rigidity directly increases both the number and activity of invadopodia. This mechanosensing is regulated by the contractile machinery of the cells (e.g, myosin II and Rho kinase).146 Matrix organization can also affect invadopodia shape. For example, tumor cells cultured on a fibrillar collagen I matrix form linear F-actin structures, which share features with conventional invadosomes, and are capable of degrading the matrix.147

To date, it is not clear which adhesion proteins participate in formation of the ring in periphery of the invadopodia core. Are they all co localized in the ring, both spatially and temporally, or are there differential kinetics and localization for each protein, as reported for focal adhesions?148,149 Blocking of integrin-mediated adhesion didn’t block invadopodia formation; yet, it reduced the extent of matrix degradation.52 These and other results raise many questions about the role of the adhesive domain in recruitment of the degradation machinery, and the cross-talk between them. Which of the adhesion components are important for invadopodia formation and function? Why do they appear primarily at the early stages of the invadopodia formation? Are there other roles for the adhesion molecules in the invasion process? Does adhesion to the ECM stabilize invadopodia mechanically? Are there differences between the adhesion mechanism, structure, and dynamics in 2D vs. 3D matrices? What is the interplay between the adhesive domain, and other cytoskeletal components?

An Integrated View of Invadopodia’s Functional Architecture

In this article, we attempted to review the structure–function relationships in invadopodia, focusing on structures that carry out specific functions in driving cell invasion, which distinguish them from other types of cellular protrusions (e.g., filopodia or lamellipodia) or other adhesion sites (e.g., focal adhesions or podosomes). Unique to invadopodia is the spatial and temporal coordination of invasion, adhesion, and matrix degradation. Each of these three processes is regulated and executed by a set of multiple proteins that can be define as a “functional domain,” the spatial organization of which is schematically depicted in Figure 1B.

The overall “mission” of invadopodia is the promotion of cell migration across connective tissue barriers (commonly practiced by metastatic cancer cells), as opposed to locomotion along specific, pre-existing migration tracks (as physiologically occurs during organogenesis and embryogenesis). The special property of these three functional domains of invadopodia is their spatial organization and temporal coordination, which enables them to act in concert, in what might be described as a coherent “grip-soften-push” mechanism. Such tactics require fine-tuned cross-talk between the proteolytic (enzymatic), invasive (cytoskeletal), and adhesive domains.

According to this view, the cell utilizes its integrin adhesion machinery to probe the ECM and bind to it (the “grip” step). Upon appropriate stimulation, global or local, actin nucleation is initiated at the cytoplasmic aspects of these adhesions, forming an initial actin core. Subsequently, the proteolytic domain is activated, presenting MT1-MMP on the ventral cell surface, and releasing MMP2 and MMP9. Focal degradation of the matrix by MT1-MMP, and broader degradation by the soluble proteases, reduces matrix barriers under and around invadopodia (the “softening” step), conditioning these areas for the penetration step. Naturally, ECM degradation can also affect nearby adhesion to the matrix by remodeling the ECM, which may explain the observation that not all invadopodia are associated with adhesion rings. Next, rigorous actin polymerization in the core of the invasive domain pushes against the plasma membrane, driving the penetration into the “softened” matrix (the “push” step). Repeated cycles of this “grip-soften-push” by multiple invadopodia could effectively constitute the mechanism underlying invadopodia-mediated cell invasion. Recent evidence for repeating cycles of protrusion and retraction of invadopodia was indeed described.150

The three functional domains of invadopodia, which are discussed above, are in fact, packed into one coherent structure presented in the transmission electron micrograph, shown in Figure 3. Transmission electron micrographs of invadopodia were shown previously in several cell types.33,54,83 In the ultrathin section shown here, cut perpendicular to the plane of the gelatin matrix, a single invadopod is seen, pushing against the gelatin layer and apparently compressing or degrading it. The invadopod itself is packed with F-actin fibers, and is devoid of cytoplasmic organelles. Microtubules are often detected at the periphery of the core actin bundle (indicated by the arrow in Fig. 3). Interestingly, the gelatin layer at the peripheral aspect of the invadopod is slightly thicker, in line with the possibility that this region correspond to the adhesion ring. Naturally, invadopodia formed by cultured cells, growing on thin ECM, are rather shallow structures compared with their in vivo counterparts, yet the general distributions of their functional/structural domains might be quite similar.

graphic file with name cam-8-215-g3.jpg

Figure 3. Imaging of invadopodia by electron microscopy: A375, human metastatic melanoma cells were cultured for 2h on glass-bottom dishes, coated with cross-linked gelatin. Cells were fixed (3% paraformaldehyde, 2% glutaraldehyde, 5 mM CaCl2) in 0.1 M cacodylate buffer (pH 7.4) for 1h, washed, and post-fixed with 1% OsO4. Samples were washed again with 0.1 M cacodylate buffer and stained with 2% aqueous uranyl acetate (EMS) for 1h, dehydrated, and embedded in Epon. Ultrathin sections were then cut and examined in an FEI Tecnai™ Spirit T12 transmission electron microscope. In this electron micrograph actin filaments are apparent throughout the core of the invadopodial protrusion, excluding other cytoplasmic structures (e.g., ribosomes) from the core area. The ventral membrane at the invadopode area is in close contact with the glass and the gelatin layer is cleared.

It should be acknowledged that despite our vast information about invadopodia, their structure, and their physiological roles, we are still left with many basic, as yet unanswered questions concerning their coordinated action. To mention a few: are there special features of the ECM (composition, rigidity, topography) that contribute to the assembly and activation of the different domains of invadopodia? How does MMP enzymatic activity affect invadopodia formation, adhesion, and mechanics? How is the timing of the different phases in the “invasion cycle” controlled and coordinated? Answers to these and other open questions may provide a clearer sense of the mechanisms underlying cancer invasion and metastasis and, hopefully, pave the way toward novel and effective therapies.

Disclosure of Potential Conflicts of Interest

No potential conflicts of interest were disclosed.

Acknowledgments

We would like to acknowledge the support of the FP7-PEOPLE-ITN-2008:Marie Curie Action T3Net in the Research of invadopodia in our laboratory. BG is the incumbent of the Erwin Neter Professorial Chair in Cell and Tumor Biology.

10.4161/cam.27842

References

  • 1.Linder S. The matrix corroded: podosomes and invadopodia in extracellular matrix degradation. Trends Cell Biol. 2007;17:107–17. doi: 10.1016/j.tcb.2007.01.002. [DOI] [PubMed] [Google Scholar]
  • 2.Murphy DA, Courtneidge SA. The ‘ins’ and ‘outs’ of podosomes and invadopodia: characteristics, formation and function. Nat Rev Mol Cell Biol. 2011;12:413–26. doi: 10.1038/nrm3141. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Gimona M, Buccione R, Courtneidge SA, Linder S. Assembly and biological role of podosomes and invadopodia. Curr Opin Cell Biol. 2008;20:235–41. doi: 10.1016/j.ceb.2008.01.005. [DOI] [PubMed] [Google Scholar]
  • 4.Linder S, Wiesner C, Himmel M. Degrading devices: invadosomes in proteolytic cell invasion. Annu Rev Cell Dev Biol. 2011;27:185–211. doi: 10.1146/annurev-cellbio-092910-154216. [DOI] [PubMed] [Google Scholar]
  • 5.Caldieri G, Ayala I, Attanasio F, Buccione R. Cell and molecular biology of invadopodia. Int Rev Cell Mol Biol. 2009;275:1–34. doi: 10.1016/S1937-6448(09)75001-4. [DOI] [PubMed] [Google Scholar]
  • 6.David-Pfeuty T, Singer SJ. Altered distributions of the cytoskeletal proteins vinculin and alpha-actinin in cultured fibroblasts transformed by Rous sarcoma virus. Proc Natl Acad Sci U S A. 1980;77:6687–91. doi: 10.1073/pnas.77.11.6687. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Tarone G, Cirillo D, Giancotti FG, Comoglio PM, Marchisio PC. Rous sarcoma virus-transformed fibroblasts adhere primarily at discrete protrusions of the ventral membrane called podosomes. Exp Cell Res. 1985;159:141–57. doi: 10.1016/S0014-4827(85)80044-6. [DOI] [PubMed] [Google Scholar]
  • 8.Carley WW, Barak LS, Webb WW. F-actin aggregates in transformed cells. J Cell Biol. 1981;90:797–802. doi: 10.1083/jcb.90.3.797. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Carley WW, Bretscher A, Webb WW. F-actin aggregates in transformed cells contain alpha-actinin and fimbrin but apparently lack tropomyosin. Eur J Cell Biol. 1986;39:313–20. [PubMed] [Google Scholar]
  • 10.Shriver K, Rohrschneider L. Organization of pp60src and selected cytoskeletal proteins within adhesion plaques and junctions of Rous sarcoma virus-transformed rat cells. J Cell Biol. 1981;89:525–35. doi: 10.1083/jcb.89.3.525. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Chen WT, Chen JM, Parsons SJ, Parsons JT. Local degradation of fibronectin at sites of expression of the transforming gene product pp60src. Nature. 1985;316:156–8. doi: 10.1038/316156a0. [DOI] [PubMed] [Google Scholar]
  • 12.Chen WT. Proteolytic activity of specialized surface protrusions formed at rosette contact sites of transformed cells. J Exp Zool. 1989;251:167–85. doi: 10.1002/jez.1402510206. [DOI] [PubMed] [Google Scholar]
  • 13.Mueller SC, Yeh Y, Chen WT. Tyrosine phosphorylation of membrane proteins mediates cellular invasion by transformed cells. J Cell Biol. 1992;119:1309–25. doi: 10.1083/jcb.119.5.1309. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Zambonin-Zallone A, Teti A, Carano A, Marchisio PC. The distribution of podosomes in osteoclasts cultured on bone laminae: effect of retinol. J Bone Miner Res. 1988;3:517–23. doi: 10.1002/jbmr.5650030507. [DOI] [PubMed] [Google Scholar]
  • 15.Kelly T, Mueller SC, Yeh Y, Chen WT. Invadopodia promote proteolysis of a wide variety of extracellular matrix proteins. J Cell Physiol. 1994;158:299–308. doi: 10.1002/jcp.1041580212. [DOI] [PubMed] [Google Scholar]
  • 16.Monsky WL, Lin CY, Aoyama A, Kelly T, Akiyama SK, Mueller SC, Chen WT. A potential marker protease of invasiveness, seprase, is localized on invadopodia of human malignant melanoma cells. Cancer Res. 1994;54:5702–10. [PubMed] [Google Scholar]
  • 17.Davies WA, Stossel TP. Peripheral hyaline blebs (podosomes) of macrophages. J Cell Biol. 1977;75:941–55. doi: 10.1083/jcb.75.3.941. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Kanehisa J, Yamanaka T, Doi S, Turksen K, Heersche JN, Aubin JE, Takeuchi H. A band of F-actin containing podosomes is involved in bone resorption by osteoclasts. Bone. 1990;11:287–93. doi: 10.1016/8756-3282(90)90082-A. [DOI] [PubMed] [Google Scholar]
  • 19.Calle Y, Burns S, Thrasher AJ, Jones GE. The leukocyte podosome. Eur J Cell Biol. 2006;85:151–7. doi: 10.1016/j.ejcb.2005.09.003. [DOI] [PubMed] [Google Scholar]
  • 20.Hai CM, Hahne P, Harrington EO, Gimona M. Conventional protein kinase C mediates phorbol-dibutyrate-induced cytoskeletal remodeling in a7r5 smooth muscle cells. Exp Cell Res. 2002;280:64–74. doi: 10.1006/excr.2002.5592. [DOI] [PubMed] [Google Scholar]
  • 21.Génot E. [The endothelial podosome] Med Sci (Paris) 2009;25:168–74. doi: 10.1051/medsci/2009252168. [DOI] [PubMed] [Google Scholar]
  • 22.Chen WT, Lee CC, Goldstein L, Bernier S, Liu CH, Lin CY, Yeh Y, Monsky WL, Kelly T, Dai M, et al. Membrane proteases as potential diagnostic and therapeutic targets for breast malignancy. Breast Cancer Res Treat. 1994;31:217–26. doi: 10.1007/BF00666155. [DOI] [PubMed] [Google Scholar]
  • 23.Sutoh M, Hashimoto Y, Yoneyama T, Yamamoto H, Hatakeyama S, Koie T, Okamoto A, Yamaya K, Saitoh H, Funyu T, et al. Invadopodia formation by bladder tumor cells. Oncol Res. 2010;19:85–92. doi: 10.3727/096504010X12875107808008. [DOI] [PubMed] [Google Scholar]
  • 24.Hwang YS, Park KK, Chung WY. Invadopodia formation in oral squamous cell carcinoma: the role of epidermal growth factor receptor signalling. Arch Oral Biol. 2012;57:335–43. doi: 10.1016/j.archoralbio.2011.08.019. [DOI] [PubMed] [Google Scholar]
  • 25.Desai B, Ma T, Chellaiah MA. Invadopodia and matrix degradation, a new property of prostate cancer cells during migration and invasion. J Biol Chem. 2008;283:13856–66. doi: 10.1074/jbc.M709401200. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Gligorijevic B, Wyckoff J, Yamaguchi H, Wang Y, Roussos ET, Condeelis J. N-WASP-mediated invadopodium formation is involved in intravasation and lung metastasis of mammary tumors. J Cell Sci. 2012;125:724–34. doi: 10.1242/jcs.092726. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Baldassarre M, Ayala I, Beznoussenko G, Giacchetti G, Machesky LM, Luini A, Buccione R. Actin dynamics at sites of extracellular matrix degradation. Eur J Cell Biol. 2006;85:1217–31. doi: 10.1016/j.ejcb.2006.08.003. [DOI] [PubMed] [Google Scholar]
  • 28.Yamaguchi H, Lorenz M, Kempiak S, Sarmiento C, Coniglio S, Symons M, Segall J, Eddy R, Miki H, Takenawa T, et al. Molecular mechanisms of invadopodium formation: the role of the N-WASP-Arp2/3 complex pathway and cofilin. J Cell Biol. 2005;168:441–52. doi: 10.1083/jcb.200407076. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Linder S, Aepfelbacher M. Podosomes: adhesion hot-spots of invasive cells. Trends Cell Biol. 2003;13:376–85. doi: 10.1016/S0962-8924(03)00128-4. [DOI] [PubMed] [Google Scholar]
  • 30.Ayala I, Baldassarre M, Caldieri G, Buccione R. Invadopodia: a guided tour. Eur J Cell Biol. 2006;85:159–64. doi: 10.1016/j.ejcb.2005.09.005. [DOI] [PubMed] [Google Scholar]
  • 31.Artym VV, Matsumoto K, Mueller SC, Yamada KM. Dynamic membrane remodeling at invadopodia differentiates invadopodia from podosomes. Eur J Cell Biol. 2011;90:172–80. doi: 10.1016/j.ejcb.2010.06.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Oser M, Dovas A, Cox D, Condeelis J. Nck1 and Grb2 localization patterns can distinguish invadopodia from podosomes. Eur J Cell Biol. 2011;90:181–8. doi: 10.1016/j.ejcb.2010.08.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Buccione R, Caldieri G, Ayala I. Invadopodia: specialized tumor cell structures for the focal degradation of the extracellular matrix. Cancer Metastasis Rev. 2009;28:137–49. doi: 10.1007/s10555-008-9176-1. [DOI] [PubMed] [Google Scholar]
  • 34.Eckert MA, Lwin TM, Chang AT, Kim J, Danis E, Ohno-Machado L, Yang J. Twist1-induced invadopodia formation promotes tumor metastasis. Cancer Cell. 2011;19:372–86. doi: 10.1016/j.ccr.2011.01.036. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Jacob A, Jing J, Lee J, Schedin P, Gilbert SM, Peden AA, Junutula JR, Prekeris R. Rab40b regulates trafficking of MMP2 and MMP9 during invadopodia formation and invasion of breast cancer cells. J Cell Sci. 2013;126:4647–58. doi: 10.1242/jcs.126573. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Artym VV, Zhang Y, Seillier-Moiseiwitsch F, Yamada KM, Mueller SC. Dynamic interactions of cortactin and membrane type 1 matrix metalloproteinase at invadopodia: defining the stages of invadopodia formation and function. Cancer Res. 2006;66:3034–43. doi: 10.1158/0008-5472.CAN-05-2177. [DOI] [PubMed] [Google Scholar]
  • 37.Nakahara H, Howard L, Thompson EW, Sato H, Seiki M, Yeh Y, Chen WT. Transmembrane/cytoplasmic domain-mediated membrane type 1-matrix metalloprotease docking to invadopodia is required for cell invasion. Proc Natl Acad Sci U S A. 1997;94:7959–64. doi: 10.1073/pnas.94.15.7959. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Bourguignon LY, Gunja-Smith Z, Iida N, Zhu HB, Young LJ, Muller WJ, Cardiff RD. CD44v(3,8-10) is involved in cytoskeleton-mediated tumor cell migration and matrix metalloproteinase (MMP-9) association in metastatic breast cancer cells. J Cell Physiol. 1998;176:206–15. doi: 10.1002/(SICI)1097-4652(199807)176:1<206::AID-JCP22>3.0.CO;2-3. [DOI] [PubMed] [Google Scholar]
  • 39.Clark ES, Whigham AS, Yarbrough WG, Weaver AM. Cortactin is an essential regulator of matrix metalloproteinase secretion and extracellular matrix degradation in invadopodia. Cancer Res. 2007;67:4227–35. doi: 10.1158/0008-5472.CAN-06-3928. [DOI] [PubMed] [Google Scholar]
  • 40.Poincloux R, Lizárraga F, Chavrier P. Matrix invasion by tumour cells: a focus on MT1-MMP trafficking to invadopodia. J Cell Sci. 2009;122:3015–24. doi: 10.1242/jcs.034561. [DOI] [PubMed] [Google Scholar]
  • 41.Monsky WL, Kelly T, Lin CY, Yeh Y, Stetler-Stevenson WG, Mueller SC, Chen WT. Binding and localization of M(r) 72,000 matrix metalloproteinase at cell surface invadopodia. Cancer Res. 1993;53:3159–64. [PubMed] [Google Scholar]
  • 42.Schnaeker EM, Ossig R, Ludwig T, Dreier R, Oberleithner H, Wilhelmi M, Schneider SW. Microtubule-dependent matrix metalloproteinase-2/matrix metalloproteinase-9 exocytosis: prerequisite in human melanoma cell invasion. Cancer Res. 2004;64:8924–31. doi: 10.1158/0008-5472.CAN-04-0324. [DOI] [PubMed] [Google Scholar]
  • 43.Itoh Y, Seiki M. MT1-MMP: a potent modifier of pericellular microenvironment. J Cell Physiol. 2006;206:1–8. doi: 10.1002/jcp.20431. [DOI] [PubMed] [Google Scholar]
  • 44.Bravo-Cordero JJ, Marrero-Diaz R, Megías D, Genís L, García-Grande A, García MA, Arroyo AG, Montoya MC. MT1-MMP proinvasive activity is regulated by a novel Rab8-dependent exocytic pathway. EMBO J. 2007;26:1499–510. doi: 10.1038/sj.emboj.7601606. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Wiesner C, El Azzouzi K, Linder S. A specific subset of RabGTPases controls cell surface exposure of MT1-MMP, extracellular matrix degradation and three-dimensional invasion of macrophages. J Cell Sci. 2013;126:2820–33. doi: 10.1242/jcs.122358. [DOI] [PubMed] [Google Scholar]
  • 46.Nyalendo C, Michaud M, Beaulieu E, Roghi C, Murphy G, Gingras D, Béliveau R. Src-dependent phosphorylation of membrane type I matrix metalloproteinase on cytoplasmic tyrosine 573: role in endothelial and tumor cell migration. J Biol Chem. 2007;282:15690–9. doi: 10.1074/jbc.M608045200. [DOI] [PubMed] [Google Scholar]
  • 47.Brown MD, Sacks DB. IQGAP1 in cellular signaling: bridging the GAP. Trends Cell Biol. 2006;16:242–9. doi: 10.1016/j.tcb.2006.03.002. [DOI] [PubMed] [Google Scholar]
  • 48.Sakurai-Yageta M, Recchi C, Le Dez G, Sibarita JB, Daviet L, Camonis J, D’Souza-Schorey C, Chavrier P. The interaction of IQGAP1 with the exocyst complex is required for tumor cell invasion downstream of Cdc42 and RhoA. J Cell Biol. 2008;181:985–98. doi: 10.1083/jcb.200709076. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Clark ES, Weaver AM. A new role for cortactin in invadopodia: regulation of protease secretion. Eur J Cell Biol. 2008;87:581–90. doi: 10.1016/j.ejcb.2008.01.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Wolf K, Mazo I, Leung H, Engelke K, von Andrian UH, Deryugina EI, Strongin AY, Bröcker EB, Friedl P. Compensation mechanism in tumor cell migration: mesenchymal-amoeboid transition after blocking of pericellular proteolysis. J Cell Biol. 2003;160:267–77. doi: 10.1083/jcb.200209006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Wolf K, Wu YI, Liu Y, Geiger J, Tam E, Overall C, Stack MS, Friedl P. Multi-step pericellular proteolysis controls the transition from individual to collective cancer cell invasion. Nat Cell Biol. 2007;9:893–904. doi: 10.1038/ncb1616. [DOI] [PubMed] [Google Scholar]
  • 52.Branch KM, Hoshino D, Weaver AM. Adhesion rings surround invadopodia and promote maturation. Biol Open. 2012;1:711–22. doi: 10.1242/bio.20121867. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Beaty BT, Sharma VP, Bravo-Cordero JJ, Simpson MA, Eddy RJ, Koleske AJ, Condeelis J. β1 integrin regulates Arg to promote invadopodial maturation and matrix degradation. Mol Biol Cell. 2013;24:1661–75, S1-11. doi: 10.1091/mbc.E12-12-0908. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Baldassarre M, Pompeo A, Beznoussenko G, Castaldi C, Cortellino S, McNiven MA, Luini A, Buccione R. Dynamin participates in focal extracellular matrix degradation by invasive cells. Mol Biol Cell. 2003;14:1074–84. doi: 10.1091/mbc.E02-05-0308. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.McNiven MA, Baldassarre M, Buccione R. The role of dynamin in the assembly and function of podosomes and invadopodia. Front Biosci. 2004;9:1944–53. doi: 10.2741/1348. [DOI] [PubMed] [Google Scholar]
  • 56.Deryugina EI, Quigley JP. Matrix metalloproteinases and tumor metastasis. Cancer Metastasis Rev. 2006;25:9–34. doi: 10.1007/s10555-006-7886-9. [DOI] [PubMed] [Google Scholar]
  • 57.Turk B. Targeting proteases: successes, failures and future prospects. Nat Rev Drug Discov. 2006;5:785–99. doi: 10.1038/nrd2092. [DOI] [PubMed] [Google Scholar]
  • 58.Abbenante G, Fairlie DP. Protease inhibitors in the clinic. Med Chem. 2005;1:71–104. doi: 10.2174/1573406053402569. [DOI] [PubMed] [Google Scholar]
  • 59.Konstantinopoulos PA, Karamouzis MV, Papatsoris AG, Papavassiliou AG. Matrix metalloproteinase inhibitors as anticancer agents. Int J Biochem Cell Biol. 2008;40:1156–68. doi: 10.1016/j.biocel.2007.11.007. [DOI] [PubMed] [Google Scholar]
  • 60.Sparano JA, Bernardo P, Stephenson P, Gradishar WJ, Ingle JN, Zucker S, Davidson NE. Randomized phase III trial of marimastat versus placebo in patients with metastatic breast cancer who have responding or stable disease after first-line chemotherapy: Eastern Cooperative Oncology Group trial E2196. J Clin Oncol. 2004;22:4683–90. doi: 10.1200/JCO.2004.08.054. [DOI] [PubMed] [Google Scholar]
  • 61.Zucker S, Cao J. Selective matrix metalloproteinase (MMP) inhibitors in cancer therapy: ready for prime time? Cancer Biol Ther. 2009;8:2371–3. doi: 10.4161/cbt.8.24.10353. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.Friedl P, Wolf K. Tumour-cell invasion and migration: diversity and escape mechanisms. Nat Rev Cancer. 2003;3:362–74. doi: 10.1038/nrc1075. [DOI] [PubMed] [Google Scholar]
  • 63.Yamaguchi H, Condeelis J. Regulation of the actin cytoskeleton in cancer cell migration and invasion. Biochim Biophys Acta. 2007;1773:642–52. doi: 10.1016/j.bbamcr.2006.07.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.Bromann PA, Korkaya H, Courtneidge SA. The interplay between Src family kinases and receptor tyrosine kinases. Oncogene. 2004;23:7957–68. doi: 10.1038/sj.onc.1208079. [DOI] [PubMed] [Google Scholar]
  • 65.Obergfell A, Eto K, Mocsai A, Buensuceso C, Moores SL, Brugge JS, Lowell CA, Shattil SJ. Coordinate interactions of Csk, Src, and Syk kinases with [alpha]IIb[beta]3 initiate integrin signaling to the cytoskeleton. J Cell Biol. 2002;157:265–75. doi: 10.1083/jcb.200112113. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66.Kelley LC, Ammer AG, Hayes KE, Martin KH, Machida K, Jia L, Mayer BJ, Weed SA. Oncogenic Src requires a wild-type counterpart to regulate invadopodia maturation. J Cell Sci. 2010;123:3923–32. doi: 10.1242/jcs.075200. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 67.Gatesman A, Walker VG, Baisden JM, Weed SA, Flynn DC. Protein kinase Calpha activates c-Src and induces podosome formation via AFAP-110. Mol Cell Biol. 2004;24:7578–97. doi: 10.1128/MCB.24.17.7578-7597.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 68.Bowden ET, Barth M, Thomas D, Glazer RI, Mueller SC. An invasion-related complex of cortactin, paxillin and PKCmu associates with invadopodia at sites of extracellular matrix degradation. Oncogene. 1999;18:4440–9. doi: 10.1038/sj.onc.1202827. [DOI] [PubMed] [Google Scholar]
  • 69.Destaing O, Block MR, Planus E, Albiges-Rizo C. Invadosome regulation by adhesion signaling. Curr Opin Cell Biol. 2011;23:597–606. doi: 10.1016/j.ceb.2011.04.002. [DOI] [PubMed] [Google Scholar]
  • 70.Rodriguez EM, Dunham EE, Martin GS. Atypical protein kinase C activity is required for extracellular matrix degradation and invasion by Src-transformed cells. J Cell Physiol. 2009;221:171–82. doi: 10.1002/jcp.21841. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 71.Courtneidge SA. Cell migration and invasion in human disease: the Tks adaptor proteins. Biochem Soc Trans. 2012;40:129–32. doi: 10.1042/BST20110685. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 72.Sharma VP, Eddy R, Entenberg D, Kai M, Gertler FB, Condeelis J. Tks5 and SHIP2 regulate invadopodium maturation, but not initiation, in breast carcinoma cells. Curr Biol. 2013;23:2079–89. doi: 10.1016/j.cub.2013.08.044. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 73.Gross SR. Actin binding proteins: their ups and downs in metastatic life. Cell Adh Migr. 2013;7:199–213. doi: 10.4161/cam.23176. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 74.Martinez-Quiles N, Rohatgi R, Antón IM, Medina M, Saville SP, Miki H, Yamaguchi H, Takenawa T, Hartwig JH, Geha RS, et al. WIP regulates N-WASP-mediated actin polymerization and filopodium formation. Nat Cell Biol. 2001;3:484–91. doi: 10.1038/35074551. [DOI] [PubMed] [Google Scholar]
  • 75.Hoshino D, Branch KM, Weaver AM. Signaling inputs to invadopodia and podosomes. J Cell Sci. 2013;126:2979–89. doi: 10.1242/jcs.079475. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 76.Albiges-Rizo C, Destaing O, Fourcade B, Planus E, Block MR. Actin machinery and mechanosensitivity in invadopodia, podosomes and focal adhesions. J Cell Sci. 2009;122:3037–49. doi: 10.1242/jcs.052704. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 77.Oser M, Yamaguchi H, Mader CC, Bravo-Cordero JJ, Arias M, Chen X, Desmarais V, van Rheenen J, Koleske AJ, Condeelis J. Cortactin regulates cofilin and N-WASp activities to control the stages of invadopodium assembly and maturation. J Cell Biol. 2009;186:571–87. doi: 10.1083/jcb.200812176. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 78.Sibony-Benyamini H, Gil-Henn H. Invadopodia: the leading force. Eur J Cell Biol. 2012;91:896–901. doi: 10.1016/j.ejcb.2012.04.001. [DOI] [PubMed] [Google Scholar]
  • 79.Bravo-Cordero JJ, Magalhaes MA, Eddy RJ, Hodgson L, Condeelis J. Functions of cofilin in cell locomotion and invasion. Nat Rev Mol Cell Biol. 2013;14:405–15. doi: 10.1038/nrm3609. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 80.Lizárraga F, Poincloux R, Romao M, Montagnac G, Le Dez G, Bonne I, Rigaill G, Raposo G, Chavrier P. Diaphanous-related formins are required for invadopodia formation and invasion of breast tumor cells. Cancer Res. 2009;69:2792–800. doi: 10.1158/0008-5472.CAN-08-3709. [DOI] [PubMed] [Google Scholar]
  • 81.Li A, Dawson JC, Forero-Vargas M, Spence HJ, Yu X, König I, Anderson K, Machesky LM. The actin-bundling protein fascin stabilizes actin in invadopodia and potentiates protrusive invasion. Curr Biol. 2010;20:339–45. doi: 10.1016/j.cub.2009.12.035. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 82.Jayo A, Parsons M. Fascin: a key regulator of cytoskeletal dynamics. Int J Biochem Cell Biol. 2010;42:1614–7. doi: 10.1016/j.biocel.2010.06.019. [DOI] [PubMed] [Google Scholar]
  • 83.Schoumacher M, Goldman RD, Louvard D, Vignjevic DM. Actin, microtubules, and vimentin intermediate filaments cooperate for elongation of invadopodia. J Cell Biol. 2010;189:541–56. doi: 10.1083/jcb.200909113. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 84.Lorenz M, Yamaguchi H, Wang Y, Singer RH, Condeelis J. Imaging sites of N-wasp activity in lamellipodia and invadopodia of carcinoma cells. Curr Biol. 2004;14:697–703. doi: 10.1016/j.cub.2004.04.008. [DOI] [PubMed] [Google Scholar]
  • 85.Donnelly SK, Weisswange I, Zettl M, Way M. WIP provides an essential link between Nck and N-WASP during Arp2/3-dependent actin polymerization. Curr Biol. 2013;23:999–1006. doi: 10.1016/j.cub.2013.04.051. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 86.Welch MD, Rosenblatt J, Skoble J, Portnoy DA, Mitchison TJ. Interaction of human Arp2/3 complex and the Listeria monocytogenes ActA protein in actin filament nucleation. Science. 1998;281:105–8. doi: 10.1126/science.281.5373.105. [DOI] [PubMed] [Google Scholar]
  • 87.Mullins RD, Heuser JA, Pollard TD. The interaction of Arp2/3 complex with actin: nucleation, high affinity pointed end capping, and formation of branching networks of filaments. Proc Natl Acad Sci U S A. 1998;95:6181–6. doi: 10.1073/pnas.95.11.6181. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 88.Khanduja N, Kuhn JR. Processive acceleration of actin barbed-end assembly by N-WASP. Mol Biol Cell. 2014;25:55–65. doi: 10.1091/mbc.E12-11-0781. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 89.Goley ED, Welch MD. The ARP2/3 complex: an actin nucleator comes of age. Nat Rev Mol Cell Biol. 2006;7:713–26. doi: 10.1038/nrm2026. [DOI] [PubMed] [Google Scholar]
  • 90.Otsubo T, Iwaya K, Mukai Y, Mizokami Y, Serizawa H, Matsuoka T, Mukai K. Involvement of Arp2/3 complex in the process of colorectal carcinogenesis. Mod Pathol. 2004;17:461–7. doi: 10.1038/modpathol.3800062. [DOI] [PubMed] [Google Scholar]
  • 91.Semba S, Iwaya K, Matsubayashi J, Serizawa H, Kataba H, Hirano T, Kato H, Matsuoka T, Mukai K. Coexpression of actin-related protein 2 and Wiskott-Aldrich syndrome family verproline-homologous protein 2 in adenocarcinoma of the lung. Clin Cancer Res. 2006;12:2449–54. doi: 10.1158/1078-0432.CCR-05-2566. [DOI] [PubMed] [Google Scholar]
  • 92.Weaver AM, Karginov AV, Kinley AW, Weed SA, Li Y, Parsons JT, Cooper JA. Cortactin promotes and stabilizes Arp2/3-induced actin filament network formation. Curr Biol. 2001;11:370–4. doi: 10.1016/S0960-9822(01)00098-7. [DOI] [PubMed] [Google Scholar]
  • 93.Weaver AM, Heuser JE, Karginov AV, Lee WL, Parsons JT, Cooper JA. Interaction of cortactin and N-WASp with Arp2/3 complex. Curr Biol. 2002;12:1270–8. doi: 10.1016/S0960-9822(02)01035-7. [DOI] [PubMed] [Google Scholar]
  • 94.Paz H, Pathak N, Yang J. Invading one step at a time: the role of invadopodia in tumor metastasis. Oncogene. 2013 doi: 10.1038/onc.2013.393. Forthcoming. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 95.Kanner SB, Reynolds AB, Vines RR, Parsons JT. Monoclonal antibodies to individual tyrosine-phosphorylated protein substrates of oncogene-encoded tyrosine kinases. Proc Natl Acad Sci U S A. 1990;87:3328–32. doi: 10.1073/pnas.87.9.3328. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 96.Wu H, Reynolds AB, Kanner SB, Vines RR, Parsons JT. Identification and characterization of a novel cytoskeleton-associated pp60src substrate. Mol Cell Biol. 1991;11:5113–24. doi: 10.1128/mcb.11.10.5113. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 97.Mader CC, Oser M, Magalhaes MA, Bravo-Cordero JJ, Condeelis J, Koleske AJ, Gil-Henn H. An EGFR-Src-Arg-cortactin pathway mediates functional maturation of invadopodia and breast cancer cell invasion. Cancer Res. 2011;71:1730–41. doi: 10.1158/0008-5472.CAN-10-1432. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 98.Tehrani S, Tomasevic N, Weed S, Sakowicz R, Cooper JA. Src phosphorylation of cortactin enhances actin assembly. Proc Natl Acad Sci U S A. 2007;104:11933–8. doi: 10.1073/pnas.0701077104. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 99.Li Y, Tondravi M, Liu J, Smith E, Haudenschild CC, Kaczmarek M, Zhan X. Cortactin potentiates bone metastasis of breast cancer cells. Cancer Res. 2001;61:6906–11. [PubMed] [Google Scholar]
  • 100.Oser M, Mader CC, Gil-Henn H, Magalhaes M, Bravo-Cordero JJ, Koleske AJ, Condeelis J. Specific tyrosine phosphorylation sites on cortactin regulate Nck1-dependent actin polymerization in invadopodia. J Cell Sci. 2010;123:3662–73. doi: 10.1242/jcs.068163. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 101.Weaver AM, Young ME, Lee WL, Cooper JA. Integration of signals to the Arp2/3 complex. Curr Opin Cell Biol. 2003;15:23–30. doi: 10.1016/S0955-0674(02)00015-7. [DOI] [PubMed] [Google Scholar]
  • 102.Uruno T, Liu J, Zhang P, Fan Yx, Egile C, Li R, Mueller SC, Zhan X. Activation of Arp2/3 complex-mediated actin polymerization by cortactin. Nat Cell Biol. 2001;3:259–66. doi: 10.1038/35060051. [DOI] [PubMed] [Google Scholar]
  • 103.Ayala I, Baldassarre M, Giacchetti G, Caldieri G, Tetè S, Luini A, Buccione R. Multiple regulatory inputs converge on cortactin to control invadopodia biogenesis and extracellular matrix degradation. J Cell Sci. 2008;121:369–78. doi: 10.1242/jcs.008037. [DOI] [PubMed] [Google Scholar]
  • 104.Bravo-Cordero JJ, Oser M, Chen X, Eddy R, Hodgson L, Condeelis J. A novel spatiotemporal RhoC activation pathway locally regulates cofilin activity at invadopodia. Curr Biol. 2011;21:635–44. doi: 10.1016/j.cub.2011.03.039. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 105.Yamashiro-Matsumura S, Matsumura F. Purification and characterization of an F-actin-bundling 55-kilodalton protein from HeLa cells. J Biol Chem. 1985;260:5087–97. [PubMed] [Google Scholar]
  • 106.Svitkina TM, Bulanova EA, Chaga OY, Vignjevic DM, Kojima S, Vasiliev JM, Borisy GG. Mechanism of filopodia initiation by reorganization of a dendritic network. J Cell Biol. 2003;160:409–21. doi: 10.1083/jcb.200210174. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 107.Adams JC. Roles of fascin in cell adhesion and motility. Curr Opin Cell Biol. 2004;16:590–6. doi: 10.1016/j.ceb.2004.07.009. [DOI] [PubMed] [Google Scholar]
  • 108.Sedeh RS, Fedorov AA, Fedorov EV, Ono S, Matsumura F, Almo SC, Bathe M. Structure, evolutionary conservation, and conformational dynamics of Homo sapiens fascin-1, an F-actin crosslinking protein. J Mol Biol. 2010;400:589–604. doi: 10.1016/j.jmb.2010.04.043. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 109.Anilkumar N, Parsons M, Monk R, Ng T, Adams JC. Interaction of fascin and protein kinase Calpha: a novel intersection in cell adhesion and motility. EMBO J. 2003;22:5390–402. doi: 10.1093/emboj/cdg521. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 110.Hashimoto Y, Skacel M, Adams JC. Roles of fascin in human carcinoma motility and signaling: prospects for a novel biomarker? Int J Biochem Cell Biol. 2005;37:1787–804. doi: 10.1016/j.biocel.2005.05.004. [DOI] [PubMed] [Google Scholar]
  • 111.Vignjevic D, Schoumacher M, Gavert N, Janssen KP, Jih G, Laé M, Louvard D, Ben-Ze’ev A, Robine S. Fascin, a novel target of beta-catenin-TCF signaling, is expressed at the invasive front of human colon cancer. Cancer Res. 2007;67:6844–53. doi: 10.1158/0008-5472.CAN-07-0929. [DOI] [PubMed] [Google Scholar]
  • 112.Linder S, Hüfner K, Wintergerst U, Aepfelbacher M. Microtubule-dependent formation of podosomal adhesion structures in primary human macrophages. J Cell Sci. 2000;113:4165–76. doi: 10.1242/jcs.113.23.4165. [DOI] [PubMed] [Google Scholar]
  • 113.Kopp P, Lammers R, Aepfelbacher M, Woehlke G, Rudel T, Machuy N, Steffen W, Linder S. The kinesin KIF1C and microtubule plus ends regulate podosome dynamics in macrophages. Mol Biol Cell. 2006;17:2811–23. doi: 10.1091/mbc.E05-11-1010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 114.Kikuchi K, Takahashi K. WAVE2- and microtubule-dependent formation of long protrusions and invasion of cancer cells cultured on three-dimensional extracellular matrices. Cancer Sci. 2008;99:2252–9. doi: 10.1111/j.1349-7006.2008.00927.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 115.Desmarais V, Yamaguchi H, Oser M, Soon L, Mouneimne G, Sarmiento C, Eddy R, Condeelis J. N-WASP and cortactin are involved in invadopodium-dependent chemotaxis to EGF in breast tumor cells. Cell Motil Cytoskeleton. 2009;66:303–16. doi: 10.1002/cm.20361. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 116.Caldieri G, Capestrano M, Bicanova K, Beznoussenko G, Baldassarre M, Buccione R. Polarised apical-like intracellular sorting and trafficking regulates invadopodia formation and degradation of the extracellular matrix in cancer cells. Eur J Cell Biol. 2012;91:961–8. doi: 10.1016/j.ejcb.2012.03.005. [DOI] [PubMed] [Google Scholar]
  • 117.Schmoranzer J, Kreitzer G, Simon SM. Migrating fibroblasts perform polarized, microtubule-dependent exocytosis towards the leading edge. J Cell Sci. 2003;116:4513–9. doi: 10.1242/jcs.00748. [DOI] [PubMed] [Google Scholar]
  • 118.Correia I, Chu D, Chou YH, Goldman RD, Matsudaira P. Integrating the actin and vimentin cytoskeletons. adhesion-dependent formation of fimbrin-vimentin complexes in macrophages. J Cell Biol. 1999;146:831–42. doi: 10.1083/jcb.146.4.831. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 119.Takada Y, Ye X, Simon S. The integrins. Genome Biol. 2007;8:215. doi: 10.1186/gb-2007-8-5-215. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 120.Brakebusch C, Fässler R. The integrin-actin connection, an eternal love affair. EMBO J. 2003;22:2324–33. doi: 10.1093/emboj/cdg245. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 121.Zaidel-Bar R, Itzkovitz S, Ma’ayan A, Iyengar R, Geiger B. Functional atlas of the integrin adhesome. Nat Cell Biol. 2007;9:858–67. doi: 10.1038/ncb0807-858. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 122.Geiger B, Bershadsky A. Exploring the neighborhood: adhesion-coupled cell mechanosensors. Cell. 2002;110:139–42. doi: 10.1016/S0092-8674(02)00831-0. [DOI] [PubMed] [Google Scholar]
  • 123.Bershadsky AD, Balaban NQ, Geiger B. Adhesion-dependent cell mechanosensitivity. Annu Rev Cell Dev Biol. 2003;19:677–95. doi: 10.1146/annurev.cellbio.19.111301.153011. [DOI] [PubMed] [Google Scholar]
  • 124.Chen CS. Mechanotransduction - a field pulling together? J Cell Sci. 2008;121:3285–92. doi: 10.1242/jcs.023507. [DOI] [PubMed] [Google Scholar]
  • 125.Geiger B, Spatz JP, Bershadsky AD. Environmental sensing through focal adhesions. Nat Rev Mol Cell Biol. 2009;10:21–33. doi: 10.1038/nrm2593. [DOI] [PubMed] [Google Scholar]
  • 126.Curtis A, Riehle M. Tissue engineering: the biophysical background. Phys Med Biol. 2001;46:R47–65. doi: 10.1088/0031-9155/46/4/201. [DOI] [PubMed] [Google Scholar]
  • 127.Spatz JP, Geiger B. Molecular engineering of cellular environments: cell adhesion to nano-digital surfaces. Methods Cell Biol. 2007;83:89–111. doi: 10.1016/S0091-679X(07)83005-6. [DOI] [PubMed] [Google Scholar]
  • 128.Vogel V, Sheetz M. Local force and geometry sensing regulate cell functions. Nat Rev Mol Cell Biol. 2006;7:265–75. doi: 10.1038/nrm1890. [DOI] [PubMed] [Google Scholar]
  • 129.Engler AJ, Sen S, Sweeney HL, Discher DE. Matrix elasticity directs stem cell lineage specification. Cell. 2006;126:677–89. doi: 10.1016/j.cell.2006.06.044. [DOI] [PubMed] [Google Scholar]
  • 130.Discher DE, Janmey P, Wang YL. Tissue cells feel and respond to the stiffness of their substrate. Science. 2005;310:1139–43. doi: 10.1126/science.1116995. [DOI] [PubMed] [Google Scholar]
  • 131.Parsons JT, Horwitz AR, Schwartz MA. Cell adhesion: integrating cytoskeletal dynamics and cellular tension. Nat Rev Mol Cell Biol. 2010;11:633–43. doi: 10.1038/nrm2957. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 132.Ridley AJ. Life at the leading edge. Cell. 2011;145:1012–22. doi: 10.1016/j.cell.2011.06.010. [DOI] [PubMed] [Google Scholar]
  • 133.Kirfel G, Rigort A, Borm B, Herzog V. Cell migration: mechanisms of rear detachment and the formation of migration tracks. Eur J Cell Biol. 2004;83:717–24. doi: 10.1078/0171-9335-00421. [DOI] [PubMed] [Google Scholar]
  • 134.Pignatelli J, Tumbarello DA, Schmidt RP, Turner CE. Hic-5 promotes invadopodia formation and invasion during TGF-β-induced epithelial-mesenchymal transition. J Cell Biol. 2012;197:421–37. doi: 10.1083/jcb.201108143. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 135.Nakahara H, Mueller SC, Nomizu M, Yamada Y, Yeh Y, Chen WT. Activation of beta1 integrin signaling stimulates tyrosine phosphorylation of p190RhoGAP and membrane-protrusive activities at invadopodia. J Biol Chem. 1998;273:9–12. doi: 10.1074/jbc.273.1.9. [DOI] [PubMed] [Google Scholar]
  • 136.Nakahara H, Nomizu M, Akiyama SK, Yamada Y, Yeh Y, Chen WT. A mechanism for regulation of melanoma invasion. Ligation of alpha6beta1 integrin by laminin G peptides. J Biol Chem. 1996;271:27221–4. doi: 10.1074/jbc.271.44.27221. [DOI] [PubMed] [Google Scholar]
  • 137.Mueller SC, Ghersi G, Akiyama SK, Sang QX, Howard L, Pineiro-Sanchez M, Nakahara H, Yeh Y, Chen WT. A novel protease-docking function of integrin at invadopodia. J Biol Chem. 1999;274:24947–52. doi: 10.1074/jbc.274.35.24947. [DOI] [PubMed] [Google Scholar]
  • 138.Geiger B, Yamada KM. Molecular architecture and function of matrix adhesions. Cold Spring Harb Perspect Biol. 2011;3:a005033. doi: 10.1101/cshperspect.a005033. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 139.Wolfenson H, Lavelin I, Geiger B. Dynamic regulation of the structure and functions of integrin adhesions. Dev Cell. 2013;24:447–58. doi: 10.1016/j.devcel.2013.02.012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 140.Zaidel-Bar R, Geiger B. The switchable integrin adhesome. J Cell Sci. 2010;123:1385–8. doi: 10.1242/jcs.066183. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 141.Zaidel-Bar R, Cohen M, Addadi L, Geiger B. Hierarchical assembly of cell-matrix adhesion complexes. Biochem Soc Trans. 2004;32:416–20. doi: 10.1042/BST0320416. [DOI] [PubMed] [Google Scholar]
  • 142.Schaller MD. Paxillin: a focal adhesion-associated adaptor protein. Oncogene. 2001;20:6459–72. doi: 10.1038/sj.onc.1204786. [DOI] [PubMed] [Google Scholar]
  • 143.Chan KT, Cortesio CL, Huttenlocher A. FAK alters invadopodia and focal adhesion composition and dynamics to regulate breast cancer invasion. J Cell Biol. 2009;185:357–70. doi: 10.1083/jcb.200809110. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 144.Hauck CR, Hsia DA, Ilic D, Schlaepfer DD. v-Src SH3-enhanced interaction with focal adhesion kinase at beta 1 integrin-containing invadopodia promotes cell invasion. J Biol Chem. 2002;277:12487–90. doi: 10.1074/jbc.C100760200. [DOI] [PubMed] [Google Scholar]
  • 145.Zuzga DS, Pelta-Heller J, Li P, Bombonati A, Waldman SA, Pitari GM. Phosphorylation of vasodilator-stimulated phosphoprotein Ser239 suppresses filopodia and invadopodia in colon cancer. Int J Cancer. 2012;130:2539–48. doi: 10.1002/ijc.26257. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 146.Alexander NR, Branch KM, Parekh A, Clark ES, Iwueke IC, Guelcher SA, Weaver AM. Extracellular matrix rigidity promotes invadopodia activity. Curr Biol. 2008;18:1295–9. doi: 10.1016/j.cub.2008.07.090. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 147.Juin A, Billottet C, Moreau V, Destaing O, Albiges-Rizo C, Rosenbaum J, Génot E, Saltel F. Physiological type I collagen organization induces the formation of a novel class of linear invadosomes. Mol Biol Cell. 2012;23:297–309. doi: 10.1091/mbc.E11-07-0594. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 148.Kanchanawong P, Shtengel G, Pasapera AM, Ramko EB, Davidson MW, Hess HF, Waterman CM. Nanoscale architecture of integrin-based cell adhesions. Nature. 2010;468:580–4. doi: 10.1038/nature09621. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 149.Lavelin I, Wolfenson H, Patla I, Henis YI, Medalia O, Volberg T, Livne A, Kam Z, Geiger B. Differential effect of actomyosin relaxation on the dynamic properties of focal adhesion proteins. PLoS One. 2013;8:e73549. doi: 10.1371/journal.pone.0073549. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 150.Magalhaes MA, Larson DR, Mader CC, Bravo-Cordero JJ, Gil-Henn H, Oser M, Chen X, Koleske AJ, Condeelis J. Cortactin phosphorylation regulates cell invasion through a pH-dependent pathway. J Cell Biol. 2011;195:903–20. doi: 10.1083/jcb.201103045. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Cell Adhesion & Migration are provided here courtesy of Taylor & Francis

RESOURCES